dc.contributor.author
González-Sarrías, Antonio
dc.contributor.author
Combet, Emilie
dc.contributor.author
Pinto, Paula
dc.contributor.author
Mena, Pedro
dc.contributor.author
Dall'Asta, Margherita
dc.contributor.author
Garcia Aloy, Mar
dc.contributor.author
Rodriguez-Mateos, Ana
dc.contributor.author
Gibney, Eileen R.
dc.contributor.author
Dumont, Julie
dc.contributor.author
Massaro, Marika
dc.contributor.author
Sánchez Meca, Julio
dc.contributor.author
Morand, Christine
dc.contributor.author
García-Conesa, María Teresa
dc.date.issued
2017-12-04T16:03:10Z
dc.date.issued
2017-12-04T16:03:10Z
dc.date.issued
2017-07-10
dc.date.issued
2017-12-04T16:03:10Z
dc.identifier
https://hdl.handle.net/2445/118466
dc.description.abstract
Several randomized controlled trials (RCTs) and meta-analyses support the benefits of flavanols on cardiometabolic health, but the factors affecting variability in the responses to these compounds have not been properly assessed. The objectives of this meta-analysis were to systematically collect the RCTs-based-evidence of the effects of flavanol-containing tea, cocoa and apple products on selected biomarkers of cardiometabolic risk and to explore the influence of various factors on the variability in the responses to the consumption of these products. A total of 120 RCTs were selected. Despite a high heterogeneity, the intake of the flavanol-containing products was associated using a random model with changes (reported as standardized difference in means (SDM)) in body mass index (−0.15, p < 0.001), waist circumference (−0.29, p < 0.001), total-cholesterol (−0.21, p < 0.001), LDL-cholesterol (−0.23, p < 0.001), and triacylglycerides (−0.11, p = 0.027), and with an increase of HDL-cholesterol (0.15, p = 0.005). Through subgroup analyses, we showed the influence of baseline-BMI, sex, source/form of administration, medication and country of investigation on some of the outcome measures and suggest that flavanols may be more effective in specific subgroups such as those with a BMI ≥ 25.0 kg/m2, non-medicated individuals or by specifically using tea products. This meta-analysis provides the first robust evidence of the effects induced by the consumption of flavanol-containing tea, cocoa and apple products on weight and lipid biomarkers and shows the influence of various factors that can affect their bioefficacy in humans. Of note, some of these effects are quantitatively comparable to those produced by drugs, life-style changes or other natural products. Further, RCTs in well-characterized populations are required to fully comprehend the factors affecting inter-individual responses to flavanol and thereby improve flavanols efficacy in the prevention of cardiometabolic disorders.
dc.format
application/pdf
dc.format
application/pdf
dc.relation
Reproducció del document publicat a: https://doi.org/10.3390/nu9070746
dc.relation
Nutrients, 2017, vol. 9, num. 7, p. 746
dc.relation
https://doi.org/10.3390/nu9070746
dc.rights
cc-by (c) González-Sarrías, Antonio et al., 2017
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)
dc.subject
Trastorns del metabolisme
dc.subject
Malalties cardiovasculars
dc.subject
Disorders of metabolism
dc.subject
Cardiovascular diseases
dc.title
A systematic review and meta-analysis of the effects of flavanol-containing tea, cocoa and apple products on selected cardiometabolic risk biomarkers: exploring the factors responsible for variability in their efficacy
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion